Bruker (BRKR), Newomics to Co-Market Joint MnESI-MS Platform
3/3 15:18
Bruker Corporation BRKR and Newomics Inc. recently announced collaborations on a novel liquid chromatography–mass spectrometry (LC–MS) platform for drug discovery in the Pharma/Biopharma industry and research institutions. This latest collaboration aims to build workflows...